Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study)
Francesco Patti(University of Catania), Diego Centonze(University of Rome Tor Vergata), Cristina Zuliani(University of Ferrara), Antonio Cortese(Sapienza University of Rome), Maurizia Gatto(Ospedale Generale Regionale Francesco Miulli), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Girolama Alessandra Marfia(Erasmus University Rotterdam), Roberto Bergamaschi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Paola Valentino(Magna Graecia University), Paolo Immovilli(University of Florence), Carlo Serrati(Ospedale Policlinico San Martino), M. Frigo(Azienda Ospedaliera San Gerardo), Raffaella Clerici(CTO Hospital), G. Turano, Simona Malucchi(Ospedale San Luigi Gonzaga), Rocco Totaro(San Salvatore Hospital), Clara Grazia Chisari(University of Catania), Marta Zaffira Conti(University of Bonn), Paola Banfi, Damiano Paolicelli(University of Bari Aldo Moro), Emanuele D’Amico(University of Catania), Mariano Fischetti(Istituto Neurologico Mediterraneo), Patrizia Sola(Azienda Ospedaliero-Universitaria di Modena), Stefania Leoni(Azienda Ospedaliero Universitaria di Sassari), Giorgia Teresa Maniscalco(Ospedale Antonio Cardarelli), Pietro Annovazzi(Vita-Salute San Raffaele University), Paola Perini(Azienda Ospedale - Università Padova), Roberta Fantozzi(Istituto Neurologico Mediterraneo)
Cited by 33
Related Papers
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis
|Archives of Neurology|2009|547
Multiple sclerosis in childhood: clinical features of 149 cases
|Multiple Sclerosis Journal|1997|309
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
|Multiple Sclerosis Journal|2015|298
Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica
|Journal of Neurology|2004|268